Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) traded down 5.1% during mid-day trading on Monday . The stock traded as low as $21.60 and last traded at $21.49. 291,067 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,713,280 shares. The stock had previously closed at $22.64.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. Barclays lowered their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Bank of America lowered their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Mizuho lowered their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Finally, KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.
Check Out Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Trading Up 0.7%
The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market cap of $2.08 billion, a PE ratio of 7.41, a PEG ratio of 1.46 and a beta of 1.01. The stock's 50 day simple moving average is $24.62 and its 200 day simple moving average is $33.96.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same quarter in the previous year, the company earned $0.84 EPS. The business's quarterly revenue was up .3% compared to the same quarter last year. On average, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Acadia Healthcare
Several institutional investors and hedge funds have recently modified their holdings of the stock. Inspire Investing LLC lifted its position in shares of Acadia Healthcare by 9.0% in the 1st quarter. Inspire Investing LLC now owns 11,174 shares of the company's stock worth $339,000 after purchasing an additional 925 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company's stock worth $10,337,000 after acquiring an additional 27,207 shares in the last quarter. Aristeia Capital L.L.C. bought a new position in shares of Acadia Healthcare in the 1st quarter worth about $356,000. Caxton Associates LLP bought a new position in shares of Acadia Healthcare in the 1st quarter worth about $394,000. Finally, Goldman Sachs Group Inc. increased its stake in shares of Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock worth $21,170,000 after acquiring an additional 121,444 shares in the last quarter.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
